Reversible blood-brain barrier opening utilizing the membrane active peptide melittin in vitro and in vivo.
Ontology highlight
ABSTRACT: The blood-brain barrier (BBB) tightly controls entry of molecules and cells into the brain, restricting the delivery of therapeutics. Blood-brain barrier opening (BBBO) utilizes reversible disruption of cell-cell junctions between brain microvascular endothelial cells to enable transient entry into the brain. Here, we demonstrate that melittin, a membrane active peptide present in bee venom, supports transient BBBO. From endothelial and neuronal viability studies, we first identify the accessible concentration range for BBBO. We then use a tissue-engineered model of the human BBB to optimize dosing and elucidate the mechanism of opening. Melittin and other membrane active variants transiently increase paracellular permeability via disruption of cell-cell junctions that result in transient
SUBMITTER: Linville RM
PROVIDER: S-EPMC8330225 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA